Redox dual-responsive paclitaxel-doxorubicin heterodimeric prodrug self-delivery nanoaggregates for more effective breast cancer synergistic combination chemotherapy-Reference-Cited by-同舟云学术

Redox dual-responsive paclitaxel-doxorubicin heterodimeric prodrug self-delivery nanoaggregates for more effective breast cancer synergistic combination chemotherapy

Published:2019-10 Issue: Volume:21 Page:102066
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Wang Yingli,Wang Jiamei,Yang Liyuan,Wei Wei,Sun Bingjun,Na Kexin,Song Yuxi,Zhang Haotian,He Zhonggui,Sun Jin,Wang Yongjun

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference43 articles.

1. Development of novel combination therapies;Woodcock;New Engl J Med,2011

2. Mechanisms of drug combinations: interaction and network perspectives. Nature reviews;Jia;Drug discovery,2009

3. Anticancer therapeutics: "addictive" targets, multi-targeted drugs, new drug combinations;Broxterman;Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,2005

4. Recent advances of cocktail chemotherapy by combination drug delivery systems;Hu;Adv Drug Deliv Rev,2016

5. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles;Wang;Biomaterials,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-Encapsulation of Paclitaxel and Doxorubicin in Liposomes Layer by Layer;Colloids and Interfaces;2024-07-02

2. Facile synthesis of GSH-triggered degradable hyperbranched polymer coprodrug as unimolecular micelles for precise tumor combination chemotherapy;European Polymer Journal;2024-05

3. Hyaluronic acid anchored paclitaxel nanoparticles to solubilize for drug delivery;European Polymer Journal;2023-12

4. Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics;Acta Pharmaceutica Sinica B;2023-08

5. Tailoring carrier-free nanocombo of small-molecule prodrug for combinational cancer therapy;Journal of Controlled Release;2022-12